Takeda sells $660M in assets to Stada Arzneimittel

Takeda dipped into its pool of non-core assets again and sold $660 million to Stada Arzneimittel as part of its goal to divest $10 billion in non-core assets.

What you should know:

1. Takeda sold assets related to over-the-counter vitamins and food supplements, as well as cardiovascular, diabetes, general medicine and respiratory therapeutic products.

2. Takeda has completed six similar transactions recently as it attempts to pay off debt.

3. After acquiring Shire in January 2019, Takeda became one of the largest and most indebted drugmakers in the world.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

ASC_GI_300x250

Featured Webinars

Featured Whitepapers

Featured Podcast